Expression of SEPTIN2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SEPTIN2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 336.42

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

348.5

Number of samples

141

Samples

Sample	Description	TPM
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	632.9
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	600.4
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	593.5
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	573.3
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	566.1
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	548.2
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	539.7
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	531.4
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	531.3
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	506.6
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	501.0
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	491.6
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	491.4
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	474.0
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	472.0
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	470.5
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	467.8
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	466.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	465.4
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	462.1
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	461.4
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	460.4
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	457.2
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	454.3
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	446.1
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	445.0
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	441.9
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	438.4
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	436.8
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	435.5
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	433.3
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	426.4
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	419.1
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	418.7
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	418.5
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	416.7
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	415.3
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	414.5
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	410.7
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	407.0
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	405.1
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	404.8
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	404.4
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	402.5
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	399.5
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	399.1
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	398.7
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	396.0
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	394.1
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	386.9
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	385.0
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	381.4
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	379.1
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	373.0
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	367.9
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	366.3
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	363.7
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	362.3
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	361.9
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	359.8
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	358.1
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	357.9
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	356.9
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	356.7
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	356.3
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	349.3
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	347.7
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	344.8
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	342.5
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	342.5
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	340.7
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	338.7
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	338.3
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	338.1
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	334.8
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	328.0
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	323.8
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	323.8
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	323.3
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	322.8
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	322.5
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	322.2
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	321.7
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	321.0
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	312.3
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	310.0
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	309.9
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	308.7
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	307.1
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	303.2
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	301.4
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	299.2
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	297.5
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	297.4
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	297.1
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	293.7
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	288.6
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	287.9
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	287.7
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	286.7
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	286.6
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	285.8
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	284.8
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	283.3
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	281.7
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	281.5
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	279.1
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	277.1
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	276.7
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	272.8
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	271.1
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	269.9
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	265.4
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	259.2
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	256.2
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	254.6
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	253.1
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	241.3
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	241.0
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	240.3
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	239.6
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	235.9
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	234.8
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	234.1
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	228.3
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	228.3
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	227.0
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	225.6
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	220.4
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	215.7
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	205.1
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	198.2
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	192.0
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	189.2
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	183.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	174.6
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	170.6
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	163.9
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	144.2
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	140.4
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	104.4
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SEPTIN2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 78.41

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

97.0

Number of samples

Samples

Sample	Description	TPM
AK123	N, NA, stage:NA, dead, 180 days	146.1
AK071	N, NA, stage:NA, dead, 540 days	137.0
AK035	N, NA, stage:NA, dead, 210 days	136.4
AK043	N, NA, stage:NA, alive, 660 days	134.9
AK156	N, NA, stage:NA, dead, 330 days	132.8
AK142	N, NA, stage:NA, alive, 90 days	131.3
AK079	N, NA, stage:NA, dead, 210 days	128.5
AK051	N, NA, stage:NA, dead, 360 days	126.0
AK100	N, NA, stage:NA, alive, 960 days	119.7
AK173	N, NA, stage:NA, dead, 180 days	117.1
AK089	N, NA, stage:NA, dead, 330 days	116.1
AK183	N, NA, stage:NA, alive, 360 days	116.1
AK006	N, NA, stage:NA, dead, 360 days	114.6
AK165	N, NA, stage:NA, alive, 360 days	114.3
AK081	N, NA, stage:NA, dead, 180 days	112.6
AK049	N, NA, stage:NA, dead, 180 days	111.4
AK099	N, NA, stage:NA, dead, 420 days	108.2
AK149	N, NA, stage:NA, dead, 420 days	106.5
AK213	N, NA, stage:NA, alive, 2010 days	106.2
AK002	N, NA, stage:NA, dead, 570 days	105.9
AK053	N, NA, stage:NA, dead, 300 days	105.6
AK066	N, NA, stage:NA, alive, 960 days	105.3
AK074	N, NA, stage:NA, alive, 300 days	105.3
AK098	N, NA, stage:NA, dead, 660 days	104.0
AK231	N, NA, stage:NA, dead, 240 days	103.8
AK139	N, NA, stage:NA, dead, 270 days	102.9
AK236	N, NA, stage:NA, dead, 360 days	100.3
AK153	N, NA, stage:NA, dead, 240 days	99.9
AK218	N, NA, stage:NA, dead, 180 days	99.3
AK216	N, NA, stage:NA, dead, 360 days	98.6
AK167	N, NA, stage:NA, dead, 180 days	97.9
AK015	N, NA, stage:NA, alive, 720 days	97.9
AK188	N, NA, stage:NA, alive, 420 days	97.2
AK091	N, NA, stage:NA, dead, 210 days	96.9
AK117	N, NA, stage:NA, dead, 210 days	95.8
AK088	N, NA, stage:NA, dead, 360 days	91.6
AK226	N, NA, stage:NA, dead, 360 days	91.2
AK030	N, NA, stage:NA, dead, 120 days	91.2
AK133	N, NA, stage:NA, dead, 360 days	90.2
AK134	N, NA, stage:NA, dead, 360 days	90.1
AK003	N, NA, stage:NA, dead, 600 days	89.9
AK158	N, NA, stage:NA, dead, 360 days	89.3
AK178	N, NA, stage:NA, dead, 240 days	87.2
AK055	N, NA, stage:NA, dead, 240 days	86.9
AK227	N, NA, stage:NA, alive, 300 days	81.3
AK072	N, NA, stage:NA, dead, 150 days	78.7
AK185	N, NA, stage:NA, alive, 330 days	78.1
AK103	N, NA, stage:NA, alive, 1320 days	74.5
AK005	N, NA, stage:NA, dead, 240 days	74.4
AK085	N, NA, stage:NA, alive, 660 days	74.2
AK076	N, NA, stage:NA, alive, 660 days	63.3
AK195	N, NA, stage:NA, dead, 390 days	62.5
AK124	N, NA, stage:NA, alive, 1920 days	61.7
AK205	N, NA, stage:NA, dead, 120 days	60.8
AK041	N, NA, stage:NA, alive, 810 days	57.5
AK102	N, NA, stage:NA, alive, 1740 days	47.8
AK199	N, NA, stage:NA, alive, 1860 days	42.4
AK068	N, NA, stage:NA, alive, 360 days	32.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206330003	Tumor	N/A
CPT0186100003	Tumor	N/A
CPT0123530003	Tumor	N/A
CPT0201710003	Tumor	N/A
CPT0216920008	Tumor	N/A
CPT0218890004	Tumor	N/A
CPT0224390004	Tumor	N/A
CPT0204390003	Normal	N/A
CPT0093590003	Tumor	N/A
CPT0167750004	Tumor	N/A
CPT0204400003	Normal	N/A
CPT0079790003	Tumor	N/A
CPT0218690004	Tumor	N/A
CPT0204370003	Normal	N/A
CPT0161730003	Tumor	N/A
CPT0168720003	Tumor	N/A
CPT0206880003	Tumor	N/A
CPT0189650004	Tumor	N/A
CPT0204350003	Normal	N/A
CPT0168380003	Tumor	N/A
CPT0205890003	Tumor	N/A
CPT0217880003	Tumor	N/A
CPT0206560003	Tumor	N/A
CPT0087680003	Tumor	N/A
CPT0206000004	Tumor	N/A
CPT0218670003	Tumor	N/A
CPT0204340003	Normal	N/A
CPT0189850004	Tumor	N/A
CPT0224330003	Tumor	N/A
CPT0218330004	Tumor	N/A
CPT0167640003	Tumor	N/A
CPT0002410011	Tumor	N/A
CPT0093450003	Tumor	N/A
CPT0206110003	Tumor	N/A
CPT0217430008	Tumor	N/A
CPT0217000004	Tumor	N/A
CPT0196850003	Tumor	N/A
CPT0189250003	Tumor	N/A
CPT0189570004	Tumor	N/A
CPT0162020003	Tumor	N/A
CPT0167530003	Tumor	N/A
CPT0207030003	Tumor	N/A
CPT0127420003	Tumor	N/A
CPT0205670004	Tumor	N/A
CPT0208980003	Tumor	N/A
CPT0206780003	Tumor	N/A
CPT0182500003	Tumor	N/A
CPT0217710008	Tumor	N/A
CPT0168830003	Tumor	N/A
CPT0182550003	Tumor	N/A
CPT0189460003	Tumor	N/A
CPT0167860004	Tumor	N/A
CPT0125220003	Tumor	N/A
CPT0171580008	Tumor	N/A
CPT0087730003	Tumor	N/A
CPT0104330003	Tumor	N/A
CPT0168590003	Tumor	N/A
CPT0205450004	Tumor	N/A
CPT0219080004	Tumor	N/A
CPT0087570003	Tumor	N/A
CPT0162140003	Tumor	N/A
CPT0175060003	Tumor	N/A
CPT0205780003	Tumor	N/A
CPT0218960004	Tumor	N/A
CPT0064650003	Tumor	N/A
CPT0125570003	Tumor	N/A
CPT0190360004	Tumor	N/A
CPT0206670004	Tumor	N/A
CPT0204380003	Normal	N/A
CPT0092440003	Tumor	N/A
CPT0162100003	Tumor	N/A
CPT0221180003	Tumor	N/A
CPT0225760003	Tumor	N/A
CPT0093510003	Tumor	N/A
CPT0190240004	Tumor	N/A
CPT0228220003	Tumor	N/A
CPT0204410003	Normal	N/A
CPT0224540004	Tumor	N/A
CPT0209440003	Tumor	N/A
CPT0089150003	Tumor	N/A
CPT0204360003	Normal	N/A
CPT0168080003	Tumor	N/A
CPT0078580003	Tumor	N/A
CPT0127480003	Tumor	N/A
CPT0204420003	Normal	N/A
CPT0218830004	Tumor	N/A
CPT0225730003	Tumor	N/A
CPT0093360003	Tumor	N/A
CPT0168270003	Tumor	N/A
CPT0206450003	Tumor	N/A
CPT0207090003	Tumor	N/A
CPT0104220003	Tumor	N/A
CPT0224600003	Tumor	N/A
CPT0087950003	Tumor	N/A
CPT0204330003	Normal	N/A
CPT0199770003	Tumor	N/A
CPT0205570003	Tumor	N/A
CPT0093550003	Tumor	N/A
CPT0167970003	Tumor	N/A
CPT0182580003	Tumor	N/A
CPT0168480003	Tumor	N/A
CPT0206230003	Tumor	N/A
CPT0189750004	Tumor	N/A
CPT0217100003	Tumor	N/A
CPT0064890003	Tumor	N/A
CPT0217190003	Tumor	N/A
CPT0218770003	Tumor	N/A
CPT0125510003	Tumor	N/A
CPT0217060003	Tumor	N/A
CPT0071100003	Tumor	N/A
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA018481	Antibody CAB017190
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade